The role of cystatin C in multiple myeloma

Introduction Renal insufficiency is one of the common complications in multiple myeloma (MM) and an independent factor indicating a poor prognosis. Cystatin C (Cys C) is considered to be expected to replace creatinine to calculate glomerular filtration rate due to its own characteristics. Gene expre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of laboratory hematology 2022-02, Vol.44 (1), p.135-141
Hauptverfasser:	Zhang, Jie, Jiang, Yijing, Guo, Dan, Liu, Hai yan, Hong, Lemin, Qi, Jing, Huang, Hongming
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biomarkers, Tumor Bone marrow Creatinine Cystatin C cystatin C (cys C) Cystatin C - blood Disease Management Disease Progression Disease Susceptibility Female Gene expression Glomerular filtration rate Hemoglobin Humans Male Medical prognosis Middle Aged Multiple myeloma multiple myeloma (MM) Multiple Myeloma - blood Multiple Myeloma - diagnosis Multiple Myeloma - etiology Multiple Myeloma - mortality overall survival (OS) Prognosis progression‐free survival (PFS) Renal insufficiency Statistical analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!